Attenuation of IL-2 receptor signaling by CD4-ligation requires polymerized cytoskeletal actin but not P56LCK

By Goebel J.   Franks A.   Robey F.   Mikovits J.   Lowry R.P.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 822-824

Elsevier

Access to resources Recommend Favorite

Adenosine A2A receptor agonist ameliorates EAE and correlates with Th1 cytokine‐induced blood brain barrier dysfunction via suppression of MLCK signaling pathway

By  

Immunity, Inflammation And Disease, Vol. 6, Iss. 1, 2018-03 ,pp. : 72-80

John Wiley & Sons Inc

Access to resources Recommend Favorite

Modulation of type I IL-1 receptor and IL-1 mRNA expression followed by endotoxin treatment in the corticotropin-releasing hormone-deficient mouse

By Pournajafi Nazarloo H.   Takao T.   Taguchi T.   Ito H.   Hashimoto K.  

Journal of Neuroimmunology, Vol. 140, Iss. 1, 2003-07 ,pp. : 102-108

Elsevier

Access to resources Recommend Favorite

Deficiencies of IL-4 or TNF- receptor-1 do not diminish graft arteriosclerosis in cardiac allografts

By Nagano H.   Tilney N.L.   Stinn J.L.   Becker G.   Hasegawa S.   Libby P.   Mitchell R.N.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 152-152

Elsevier

Access to resources Recommend Favorite

Molecular mechanisms of T lymphocyte activation: convergence of T cell antigen receptor and IL-1 receptor-induced signaling at the level of IL-2 gene transcription

By Varga G.   Dreikhausen U.   Kracht M.   Appel A.   Resch K.   Szamel M.  

International Immunology, Vol. 11, Iss. 11, 1999-11 ,pp. : 1851-1862

Oxford University Press

Access to resources Recommend Favorite